0001127602-20-015653.txt : 20200506 0001127602-20-015653.hdr.sgml : 20200506 20200506171415 ACCESSION NUMBER: 0001127602-20-015653 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200504 FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nally Michael CENTRAL INDEX KEY: 0001763945 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 20853604 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-05-04 0000310158 Merck & Co., Inc. MRK 0001763945 Nally Michael MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 1 EVP, Chief Marketing Officer Common Stock 2020-05-04 4 M 0 1298 77.67 A 10273.935 D Common Stock 2020-05-04 4 F 0 565 77.67 D 9708.935 D Common Stock 2020-05-05 4 M 0 2345 76.86 A 12053.935 D Common Stock 2020-05-05 4 F 0 1020 76.86 D 11033.935 D Common Stock - 401(k) Plan 1720.848 I By 401(k) Restricted Stock Unit 2020-05-04 4 M 0 1298 0 D 2019-05-04 2021-05-04 Common Stock 1298 1300 D Restricted Stock Unit 2020-05-05 4 M 0 2345 0 D 2020-05-05 2020-05-05 Common Stock 2345 0 D Holdings include shares acquired in dividend reinvestment transactions. Includes shares acquired and dividends earned through April 7, 2020, in the Merck U.S. Savings Plan, a 401(k) plan. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. /s/ Faye C. Brown as Attorney-in-Fact for Michael Nally 2020-05-06